1,1-dichloroethene increases expression ISO RGD:1319973 6480464 vinylidene chloride results in increased expression of PBK mRNA CTD PMID:26682919 1,3-dinitrobenzene affects expression EXP 6480464 3-dinitrobenzene affects the expression of PBK mRNA CTD PMID:24140754 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of PBK mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PBK mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:1319973 6480464 Ethinyl Estradiol affects the expression of PBK mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1319973 6480464 Ethinyl Estradiol results in increased expression of PBK mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1351038 6480464 Estradiol results in decreased expression of PBK mRNA CTD PMID:20106945 17beta-estradiol increases expression ISO RGD:1351038 6480464 Estradiol results in increased expression of PBK mRNA CTD PMID:16474171 more ... 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1319973 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1319973 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319973 6480464 Tetrachlorodibenzodioxin results in increased expression of PBK mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PBK mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319973 6480464 Tetrachlorodibenzodioxin affects the expression of PBK mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1351038 6480464 Tetrachlorodibenzodioxin results in decreased expression of PBK mRNA CTD PMID:21802500 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1351038 6480464 2 more ... CTD PMID:19031421 2,4-diaminotoluene increases expression ISO RGD:1319973 6480464 2, 4-diaminotoluene results in increased expression of PBK mRNA CTD PMID:20713471 2-methylcholine affects expression ISO RGD:1351038 6480464 beta-methylcholine affects the expression of PBK mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1319973 6480464 Methylcholanthrene results in increased expression of PBK mRNA CTD PMID:20713471 4-hydroxynon-2-enal decreases expression ISO RGD:1319973 6480464 4-hydroxy-2-nonenal results in decreased expression of PBK mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1319973 6480464 Fenretinide results in increased expression of PBK mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PBK mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of PBK mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1319973 6480464 Aflatoxin B1 results in decreased expression of PBK mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1351038 6480464 Aflatoxin B1 results in decreased methylation of PBK gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PBK mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 affects expression ISO RGD:1351038 6480464 Aflatoxin B1 affects the expression of PBK protein CTD PMID:20106945 aflatoxin M1 decreases expression ISO RGD:1351038 6480464 Aflatoxin M1 results in decreased expression of PBK mRNA CTD PMID:30928695 atrazine decreases expression ISO RGD:1351038 6480464 Atrazine results in decreased expression of PBK mRNA CTD PMID:22378314 azathioprine decreases expression ISO RGD:1351038 6480464 Azathioprine results in decreased expression of PBK mRNA CTD PMID:22623647 benzalkonium chloride increases expression ISO RGD:1319973 6480464 Benzalkonium Compounds results in increased expression of PBK mRNA CTD PMID:30171875 benzo[a]pyrene decreases expression ISO RGD:1319973 6480464 Benzoapyrene results in decreased expression of PBK mRNA CTD PMID:17942131 , PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1319973 6480464 Benzoapyrene results in increased expression of PBK mRNA CTD PMID:32417428 benzo[a]pyrene increases methylation ISO RGD:1351038 6480464 Benzoapyrene results in increased methylation of PBK promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1319973 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PBK mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:1351038 6480464 Benzoapyrene results in decreased expression of PBK mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1351038 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1319973 6480464 benzobfluoranthene results in increased expression of PBK mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1319973 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PBK mRNA CTD PMID:27858113 bicalutamide decreases expression ISO RGD:1351038 6480464 bicalutamide results in decreased expression of PBK mRNA CTD PMID:15638997 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1351038 6480464 Mustard Gas results in decreased expression of PBK mRNA CTD PMID:25102026 bisphenol A affects expression ISO RGD:1351038 6480464 bisphenol A affects the expression of PBK mRNA CTD PMID:19490990 , PMID:30903817 bisphenol A increases expression ISO RGD:1319973 6480464 bisphenol A results in increased expression of PBK mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:1351038 6480464 bisphenol A results in decreased expression of PBK mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PBK mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1351038 6480464 bisphenol A results in increased expression of PBK mRNA CTD PMID:16474171 bisphenol F increases expression ISO RGD:1319973 6480464 bisphenol F results in increased expression of PBK mRNA CTD PMID:30951980 buta-1,3-diene increases expression ISO RGD:1319973 6480464 1, 3-butadiene results in increased expression of PBK mRNA CTD PMID:29038090 cadmium atom increases expression ISO RGD:1351038 6480464 Cadmium results in increased expression of PBK mRNA CTD PMID:19031421 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PBK mRNA CTD PMID:25993096 calcitriol multiple interactions ISO RGD:1351038 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of PBK mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1351038 6480464 Calcitriol results in decreased expression of PBK mRNA CTD PMID:21592394 carbon nanotube affects expression ISO RGD:1319973 6480464 Nanotubes, Carbon affects the expression of PBK mRNA CTD PMID:23845593 , PMID:25554681 carbon nanotube increases expression ISO RGD:1319973 6480464 Nanotubes, Carbon analog results in increased expression of PBK mRNA CTD PMID:25554681 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of PBK mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:1319973 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PBK mRNA CTD PMID:20938992 chrysene multiple interactions ISO RGD:1319973 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PBK mRNA CTD PMID:27858113 cisplatin multiple interactions ISO RGD:1351038 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of PBK mRNA] CTD PMID:21858171 cisplatin increases expression ISO RGD:1351038 6480464 Cisplatin results in increased expression of PBK mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1351038 6480464 cobaltous chloride results in decreased expression of PBK mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1351038 6480464 [NSC 689534 binds to Copper] which results in decreased expression of PBK mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of PBK mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:1319973 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PBK mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1351038 6480464 [NSC 689534 binds to Copper] which results in decreased expression of PBK mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of PBK mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1319973 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PBK mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1351038 6480464 Copper Sulfate results in decreased expression of PBK mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1351038 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1351038 6480464 Coumestrol results in increased expression of PBK mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1319973 6480464 Cyclosporine results in decreased expression of PBK mRNA CTD PMID:17942131 cyclosporin A decreases expression ISO RGD:1351038 6480464 Cyclosporine results in decreased expression of PBK mRNA CTD PMID:20106945 more ... cypermethrin increases expression ISO RGD:1319973 6480464 cypermethrin results in increased expression of PBK mRNA CTD PMID:29020013 dibenz[a,h]anthracene increases expression ISO RGD:1319973 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1319973 6480464 Dibutyl Phthalate results in decreased expression of PBK mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate decreases expression ISO RGD:1351038 6480464 Dibutyl Phthalate results in decreased expression of PBK mRNA CTD PMID:28973377 dichloroacetic acid increases expression ISO RGD:1319973 6480464 Dichloroacetic Acid results in increased expression of PBK mRNA CTD PMID:28962523 dicrotophos decreases expression ISO RGD:1351038 6480464 dicrotophos results in decreased expression of PBK mRNA CTD PMID:28302478 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of PBK mRNA CTD PMID:23153324 dioxygen decreases expression ISO RGD:1351038 6480464 Oxygen deficiency results in decreased expression of PBK mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1351038 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PBK mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1351038 6480464 Doxorubicin results in decreased expression of PBK mRNA CTD PMID:30031762 Enterolactone multiple interactions ISO RGD:1351038 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of PBK mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1351038 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PBK protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:1319973 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PBK mRNA CTD PMID:30517762 etoposide affects response to substance ISO RGD:1351038 6480464 PBK protein affects the susceptibility to Etoposide CTD PMID:16217747 folic acid multiple interactions ISO RGD:1319973 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PBK mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1319973 6480464 Folic Acid results in decreased expression of PBK mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1351038 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of PBK mRNA CTD PMID:24657277 furan increases expression EXP 6480464 furan results in increased expression of PBK mRNA CTD PMID:25539665 genistein affects expression ISO RGD:1351038 6480464 Genistein affects the expression of PBK mRNA CTD PMID:18847459 genistein increases expression ISO RGD:1351038 6480464 Genistein results in increased expression of PBK mRNA CTD PMID:16474171 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PBK mRNA CTD PMID:24395379 hydrogen peroxide multiple interactions EXP 6480464 PBK protein inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of MAPK1 protein] more ... CTD PMID:25065601 hydrogen peroxide increases phosphorylation EXP 6480464 Hydrogen Peroxide results in increased phosphorylation of PBK protein CTD PMID:25065601 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of PBK mRNA CTD PMID:20080153 kojic acid decreases expression ISO RGD:1351038 6480464 kojic acid results in decreased expression of PBK mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:1319973 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PBK mRNA CTD PMID:20938992 leflunomide decreases expression ISO RGD:1351038 6480464 leflunomide results in decreased expression of PBK mRNA CTD PMID:28988120 lipopolysaccharide affects expression ISO RGD:1351038 6480464 Lipopolysaccharides affects the expression of PBK mRNA CTD PMID:28070326 lipopolysaccharide multiple interactions ISO RGD:1351038 6480464 Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of PBK mRNA] CTD PMID:28070326 lucanthone decreases expression ISO RGD:1351038 6480464 Lucanthone results in decreased expression of PBK mRNA CTD PMID:21148553 methamphetamine decreases expression ISO RGD:1351038 6480464 Methamphetamine results in decreased expression of PBK mRNA CTD PMID:25290377 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of PBK mRNA CTD PMID:28341135 methotrexate multiple interactions ISO RGD:1351038 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of PBK mRNA CTD PMID:24657277 methotrexate decreases expression ISO RGD:1351038 6480464 Methotrexate results in decreased expression of PBK mRNA CTD PMID:24657277 methylparaben decreases expression ISO RGD:1351038 6480464 methylparaben results in decreased expression of PBK mRNA CTD PMID:31745603 mitomycin C affects response to substance ISO RGD:1351038 6480464 PBK protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1319973 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PBK mRNA CTD PMID:25566086 N-methyl-N-nitrosourea increases expression ISO RGD:1319973 6480464 Methylnitrosourea results in increased expression of PBK mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions ISO RGD:1319973 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PBK mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:1319973 6480464 Diethylnitrosamine results in increased expression of PBK mRNA CTD PMID:24535843 N-Nitrosopyrrolidine decreases expression ISO RGD:1351038 6480464 N-Nitrosopyrrolidine results in decreased expression of PBK mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1351038 6480464 Nickel results in increased expression of PBK mRNA CTD PMID:19031421 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PBK mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1319973 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of PBK mRNA, TTPA protein affects the reaction [Ozone results in increased expression of PBK mRNA] CTD PMID:19555225 , PMID:25658374 palbociclib decreases expression ISO RGD:1351038 6480464 palbociclib results in decreased expression of PBK mRNA CTD PMID:22869556 paracetamol decreases expression ISO RGD:1319973 6480464 Acetaminophen results in decreased expression of PBK mRNA CTD PMID:17942131 paracetamol decreases expression ISO RGD:1351038 6480464 Acetaminophen results in decreased expression of PBK mRNA CTD PMID:29067470 PCB138 multiple interactions ISO RGD:1319973 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:1351038 6480464 perfluorononanoic acid results in decreased expression of PBK mRNA CTD PMID:32588087 phenethyl isothiocyanate decreases expression ISO RGD:1351038 6480464 phenethyl isothiocyanate results in decreased expression of PBK mRNA CTD PMID:26678675 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of PBK mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:1319973 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PBK mRNA CTD PMID:24535843 phenobarbital increases expression ISO RGD:1319973 6480464 Phenobarbital results in increased expression of PBK mRNA CTD PMID:23091169 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of PBK mRNA CTD PMID:29877212 phorbol 13-acetate 12-myristate increases expression ISO RGD:1351038 6480464 Tetradecanoylphorbol Acetate results in increased expression of PBK mRNA CTD PMID:19031421 phytoestrogen increases expression ISO RGD:1351038 6480464 Phytoestrogens results in increased expression of PBK mRNA CTD PMID:18310284 pirinixic acid increases expression ISO RGD:1319973 6480464 pirinixic acid results in increased expression of PBK mRNA CTD PMID:18301758 piroxicam decreases expression ISO RGD:1351038 6480464 Piroxicam results in decreased expression of PBK mRNA CTD PMID:21858171 piroxicam multiple interactions ISO RGD:1351038 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of PBK mRNA] CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1319973 6480464 Pregnenolone Carbonitrile results in increased expression of PBK mRNA CTD PMID:27413110 progesterone increases expression ISO RGD:1351038 6480464 Progesterone results in increased expression of PBK mRNA CTD PMID:18070364 progesterone decreases expression ISO RGD:1351038 6480464 Progesterone results in decreased expression of PBK mRNA CTD PMID:21795739 propanal decreases expression ISO RGD:1351038 6480464 propionaldehyde results in decreased expression of PBK mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:1351038 6480464 Quercetin results in decreased expression of PBK mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:1351038 6480464 resveratrol results in decreased expression of PBK mRNA, resveratrol results in decreased expression of PBK protein CTD PMID:15767336 , PMID:18089832 resveratrol multiple interactions ISO RGD:1351038 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of PBK mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PBK mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1351038 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PBK mRNA CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:1319973 6480464 Asbestos, Serpentine results in increased expression of PBK mRNA CTD PMID:21514415 serpentine asbestos multiple interactions ISO RGD:1319973 6480464 SPP1 gene mutant form inhibits the reaction [Asbestos, Serpentine results in increased expression of PBK mRNA] CTD PMID:21514415 silicon dioxide increases expression ISO RGD:1319973 6480464 Silicon Dioxide results in increased expression of PBK mRNA CTD PMID:29341224 sodium arsenite increases expression ISO RGD:1351038 6480464 sodium arsenite results in increased expression of PBK mRNA CTD PMID:29301061 Soman increases expression EXP 6480464 Soman results in increased expression of PBK mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1351038 6480464 Sunitinib results in decreased expression of PBK mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:1319973 6480464 Tacrolimus results in increased expression of PBK mRNA CTD PMID:29362864 tamoxifen affects expression ISO RGD:1319973 6480464 Tamoxifen affects the expression of PBK mRNA CTD PMID:17555576 testosterone decreases expression ISO RGD:1351038 6480464 Testosterone results in decreased expression of PBK mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1351038 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of PBK mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO RGD:1351038 6480464 Tetrachloroethylene results in increased expression of PBK mRNA CTD PMID:19031421 tetrachloromethane affects expression ISO RGD:1319973 6480464 Carbon Tetrachloride affects the expression of PBK mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1319973 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PBK mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:1319973 6480464 Carbon Tetrachloride results in increased expression of PBK mRNA CTD PMID:27339419 more ... tetraphene multiple interactions ISO RGD:1319973 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PBK mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PBK mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:1319973 6480464 titanium dioxide results in increased expression of PBK mRNA CTD PMID:23557971 , PMID:27760801 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PBK mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PBK mRNA CTD PMID:25729387 Tributyltin oxide decreases expression ISO RGD:1319973 6480464 bistri-n-butyltinoxide results in decreased expression of PBK mRNA CTD PMID:17942131 trichloroethene increases expression ISO RGD:1319973 6480464 Trichloroethylene results in increased expression of PBK mRNA CTD PMID:25549359 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of PBK gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1351038 6480464 trichostatin A results in increased expression of PBK mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:1351038 6480464 Triclosan results in decreased expression of PBK mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1319973 6480464 trimellitic anhydride results in increased expression of PBK mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of PBK mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1351038 6480464 troglitazone results in decreased expression of PBK mRNA CTD PMID:19140230 tungsten increases expression ISO RGD:1319973 6480464 Tungsten results in increased expression of PBK mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1351038 6480464 Valproic Acid affects the expression of PBK mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1351038 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PBK mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1351038 6480464 Valproic Acid results in increased expression of PBK mRNA CTD PMID:23179753 , PMID:26272509 zaragozic acid A decreases expression ISO RGD:1319973 6480464 squalestatin 1 results in decreased expression of PBK mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of PBK mRNA CTD PMID:27225895 zoledronic acid decreases expression ISO RGD:1351038 6480464 zoledronic acid results in decreased expression of PBK mRNA CTD PMID:24714768